Stay updated on Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, a maintenance update that does not change substantive content.
    Difference
    0.1%
    Check dated 2026-07-28T05:59:42.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.6.3 for the Study Protocol and Statistical Analysis Plan, replacing v3.6.2. This indicates the linked documentation has been updated to the latest version.
    Difference
    0.1%
    Check dated 2026-07-06T16:40:05.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.6.0 to v3.6.2, indicating a newer revision of the document. No visible content or feature changes are indicated by the provided data.
    Difference
    0.1%
    Check dated 2026-06-29T08:53:02.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    No additions or deletions were provided, so there are no changes to evaluate. The page's described content remains as in the full context, including the study details.
    Difference
    0.2%
    Check dated 2026-06-22T09:44:02.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    New help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice states that no participants are being sought. A revision tag Revision: v3.6.0 was added, and the 'Intervention / Treatment' heading was reformatted to 'Intervention/Treatment'.
    Difference
    0.4%
    Check dated 2026-06-15T08:34:09.000Z thumbnail image
  8. Check
    51 days ago
    Change Detected
    Summary
    The page revision history shows a new entry Revision: v3.5.5, replacing the previous v3.5.4 entry. This indicates a small metadata/version update rather than any change to the study data or descriptions.
    Difference
    0.1%
    Check dated 2026-06-08T04:39:14.000Z thumbnail image

Stay in the know with updates to Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial page.